| Bruce Swarny, MD | |
|
320 Alpenglow Lane, Livingston, MT 59047 | |
| (406) 222-3541 | |
| (406) 823-6287 |
| Full Name | Bruce Swarny |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 34 Years |
| Location | 320 Alpenglow Lane, Livingston, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134291339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 8555 (Montana) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 8555 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Livingston Healthcare | Livingston, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Livingston Healthcare | 5991613598 | 49 |
News Archive
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.
Nature is a seemingly endless storehouse of interesting - and potentially life-saving - biological molecules. But tracking down and harvesting those chemicals in their natural form can be time-consuming, expensive and unreliable.
In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry - and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV
ProPublica profiles a "young invincible" and reports on what a health care overhaul might mean for him.
› Verified 2 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20031122000111 |
News Archive
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.
Nature is a seemingly endless storehouse of interesting - and potentially life-saving - biological molecules. But tracking down and harvesting those chemicals in their natural form can be time-consuming, expensive and unreliable.
In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry - and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV
ProPublica profiles a "young invincible" and reports on what a health care overhaul might mean for him.
› Verified 2 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20061104000158 |
News Archive
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.
Nature is a seemingly endless storehouse of interesting - and potentially life-saving - biological molecules. But tracking down and harvesting those chemicals in their natural form can be time-consuming, expensive and unreliable.
In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry - and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV
ProPublica profiles a "young invincible" and reports on what a health care overhaul might mean for him.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Swarny, MD 320 Alpenglow Lane, Livingston, MT 59047 Ph: (406) 222-3541 | Bruce Swarny, MD 320 Alpenglow Lane, Livingston, MT 59047 Ph: (406) 222-3541 |
News Archive
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.
Nature is a seemingly endless storehouse of interesting - and potentially life-saving - biological molecules. But tracking down and harvesting those chemicals in their natural form can be time-consuming, expensive and unreliable.
In light of several recent drug industry scandals roiling the nation's public health and raising serious questions about the US bodies that license and regulate the industry - and startling new revelations today concerning National Institutes of Health (NIH) officials and the safety of a brand name AIDS drug used to prevent mother-to-child transmission of the HIV
ProPublica profiles a "young invincible" and reports on what a health care overhaul might mean for him.
› Verified 2 days ago
Dr. Ana Despina Stan, MD, PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 320 Alpenglow Ln, Livingston, MT 59047 Phone: 406-222-3541 |